Company Profile for Palatin Technologies, Inc.Business Editors --(BUSINESS WIRE) Palatin Technologies, Inc. (AMEX AMEX See: American Stock Exchange : PTN PTN - Physical Transport Network ) is a biopharmaceutical company engaged in the drug design and development of innovative therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. . Palatin's patented drug discovery platform, MIDASTM, streamlines the drug design process with an efficient approach to identify lead compounds from protein targets for drugs. The company is currently conducting clinical investigations with its lead drug, PT-141, for the treatment of male and female sexual dysfunction sexual dysfunction Inability to experience arousal or achieve sexual satisfaction under ordinary circumstances, as a result of psychological or physiological problems. , and is developing additional therapeutic compounds, discovered using its enabling peptide platform technology MIDAS Midas (mī`dəs), in Greek mythology, king of Phrygia. Because he befriended Silenus, the oldest of the satyrs, Dionysus granted him the power to turn everything into gold by touch. , to treat obesity, sexual dysfunction and inflammation. Additionally, Palatin is developing a product for infection imaging, LeuTech(R), based on a proprietary radiolabeled monoclonal antibody monoclonal antibody, an antibody that is mass produced in the laboratory from a single clone and that recognizes only one antigen. Monoclonal antibodies are typically made by fusing a normally short-lived, antibody-producing B cell (see immunity) to a fast-growing . For further information visit the Palatin web site at www.palatin.com. -0- Company: Palatin Technologies, Inc. Headquarters Address: 4-C Cedar Brook Dr. Cranbury, NJ 08512 Main Telephone: 609-495-2200 Website: www.palatin.com Ticker: PTN(AMEX) Type of Organization: Public Industry: Health: Biotechnology Earnings Release Dates: 1st Quarter: November 15, 2003 2nd Quarter: February 15, 2003 3rd Quarter: May 15, 2003 4th Quarter: August 15, 2003 Key Executives: President/CEO: Carl Spana CFO: Stephen Wills Executive VP: Perry Molinoff Investor Relations Contact: Stephen Wills Phone: 609-495-2200 Email: swill@palatin.com |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion